Martin Shkreli invokes the Fifth Amendment and refuses to testify at House hearing

WASHINGTON — Today, the public got a disturbing window into the actions of former Turing Pharmaceuticals CEO Martin Shkreli, a sniggering, contemptuous former hedge fund manager who led a scheme to turn a profit off of price hikes on a crucial life-saving drug. At a House Oversight and Government Reform Committee hearing this morning, Shkreli…

Read More

Release of internal documents show greed driving Shkreli’s push for Turing’s massive price increase for Daraprim

Today the House Oversight Committee released a series of astonishing internal documents revealing the greed behind former Turing Pharmaceuticals CEO Martin Shkreli’s decision to increase by 5,000 percent the cost of the life-saving drug Daraprim. Daraprim is a crucial treatment for many pregnant women and people living with HIV. Last fall, then-Turing CEO Martin Shkreli…

Read More

With Shkreli gone, HRC calls on maker of Daraprim to act immediately

WASHINGTON — Following the news that Martin Shkreli has resigned as CEO of Turing Pharmaceuticals, the Human Rights Campaign (HRC), called on the drug maker’s interim CEO Ron Tilles to immediately reduce the cost of the life-saving drug Daraprim to its original price. “We hope that Martin Shkreli’s departure will mark the end of Turing…

Read More

Martin Shkreli arrested on securities fraud charges

Martin Shkreli, the CEO of Turing Pharmaeauticals, who infamously raised the price of a drug used to treat an infection particularly hazardous for people with HIV was arrested today on charges of securities fraud, reports Bloomberg Business. According to prosecutors, Shkreli’s arrest today is unconnected to the price hike of Daraprim which he raised from $13.50 to…

Read More

Martin Shkreli on Daraprim price hike: ‘I would have raised prices higher’

With his latest interview, Turing Pharmaceuticals CEO Martin Shkreli has officially cemented his place as the worst person in the world and poster child for pharmaceutical greed. Speaking at the Forbes Healthcare Summit during a 25-minute interview Shkreli said, “ I would have raised prices higher,” after being asked how he would re-do the past…

Read More

Low-cost alternative to Daraprim emerges

Express Scripts announced Tuesday that it will partner with Imprimis Pharmaceuticals to offer a low-cost alternative to Daraprim, a lifesaving treatment for people living with HIV. Two months ago, Turing Pharmaceuticals’ CEO Martin Shkreli bought the rights to Daraprim and hiked the price of this crucial drug by 5,000 percent overnight. Express Scripts, a major…

Read More

Bernie Sanders gives Turing Pharmaceuticals CEO’s donation to an HIV Clinic

Democratic presidential hopeful Bernie Sanders has given the donation of a pharmaceutical CEO who controversially raised the price of an AIDS medication to a Washington, D.C.-based clinic that specializes in the treatment of HIV patients and the LGBT community, reports The Advocate. Martin Shkreli, the CEO of Turing Pharmaceuticals, had donated $2,700 to the Sanders…

Read More

New York Attorney General launches antitrust inquiry into Turing Pharmaceuticals’ distribution practices

WASHINGTON — Today, at the urging of the Human Rights Campaign (HRC), the New York attorney general has begun investigating whether Turing Pharmaceuticals, which recently imposed an unconscionable 5,000 percent price hike on the life-saving drug Daraprim, may have violated antitrust laws by limiting its distribution. Chad Griffin, President of HRC, the nation’s largest lesbian,…

Read More

HRC president calls on manufacturer to roll back 5,000 percent price hike on HIV drug

WASHINGTON – Human Rights Campaign (HRC) President Chad Griffin today issued an open letter to Turing Pharmaceuticals CEO Martin Shkreli, calling on him to rescind his outrageous 5,000 percent price increase for Daraprim, a drug used to treat people with compromised immune systems, including those living with HIV. The drug, called Daraprim, was acquired in…

Read More